NMDAR Hypofunction Animal Models of Schizophrenia

The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to help understand the etiology and pathophysiology of schizophrenia. This hypothesis was based on early observations that NMDAR antagonists could induce a full range of symptoms of schizophrenia in normal human subj...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in molecular neuroscience Vol. 12; p. 185
Main Authors Lee, Gloria, Zhou, Yi
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 31.07.2019
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to help understand the etiology and pathophysiology of schizophrenia. This hypothesis was based on early observations that NMDAR antagonists could induce a full range of symptoms of schizophrenia in normal human subjects. Accumulating evidence in humans and animal studies points to NMDAR hypofunctionality as a convergence point for various symptoms of schizophrenia. Here we review animal models of NMDAR hypofunction generated by pharmacological and genetic approaches, and how they relate to the pathophysiology of schizophrenia. In addition, we discuss the limitations of animal models of NMDAR hypofunction and their potential utility for therapeutic applications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Reviewed by: Dennis Kätzel, University of Ulm, Germany; Jae-Ick Kim, Ulsan National Institute of Science and Technology, South Korea
Edited by: Xiaona Du, Hebei Medical University, China
ISSN:1662-5099
1662-5099
DOI:10.3389/fnmol.2019.00185